Skip to main navigation
GH Research Logo

    Investor Relations

  • Home
  • News & Presentations
    News Releases Presentations
  • Stock
    Stock Quote & Chart Historic Price Lookup Investment Calculator
  • Corporate Governance
    Documents & Charters Board of Directors Management Committee Composition
  • Financial Information
    SEC Filings

News Releases

May 18, 2022
GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates
DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the first quarter ended March 31, 2022 and gave
Mar 28, 2022
GH Research Reports Full Year 2021 Financial Results and Provides Business Updates
DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2021 and gave

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • © GH Research 2022